36
Participants
Start Date
December 31, 2014
Primary Completion Date
July 12, 2017
Study Completion Date
July 12, 2017
Blood Draw
Blood draws (65 mLs \[\~4 tablespoons\] per blood draw) at 4 time points: Prior to study medication initiation, and at +6, +12 and+24 months post treatment initiation.
CSF collection by lumbar puncture (Optional)
For participants who volunteer to donate CSF samples: up to 25 mLs (\<2 tablespoons): prior to study medication initiation, and at month 24 post treatment initiation.
South Shore Neurologic Associates - Multiple Sclerosis Care Center, Patchogue
Carolinas Medical Center (CMC), Charlotte
Cleveland Clinic: Mellen Center for Multiple Sclerosis, Cleveland
University of Michigan Health System -Multiple Sclerosis Center, Ann Arbor
Henry Ford Health System, Detroit
Minneapolis Clinic of Neurology, Golden Valley
University of Colorado, Aurora
University of New Mexico: Health Sciences Center, Albuquerque
University of Southern California, Los Angeles
Jordan Research & Education Institute: Sutter Alta Bates Summit, Berkeley
University of California, Davis, Sacramento
Providence Multiple Sclerosis Center, Portland
Swedish Neuroscience Institute, Seattle
Collaborators (1)
Autoimmunity Centers of Excellence
OTHER
Novartis Pharmaceuticals
INDUSTRY
National Institute of Allergy and Infectious Diseases (NIAID)
NIH